{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T04:02:03Z","timestamp":1791172923344,"version":"4.1.0"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,5,31]]},"DOI":"10.1097\/qad.0b013e328133f285","type":"journal-article","created":{"date-parts":[[2007,5,11]],"date-time":"2007-05-11T04:10:48Z","timestamp":1178856648000},"page":"1185-1197","source":"Crossref","is-referenced-by-count":228,"title":["Prognosis of HIV-1-infected patients up to 5 years after initiation of HAART: collaborative analysis of prospective studies"],"prefix":"10.1097","volume":"21","member":"276","reference":[{"key":"R1-12-20210130","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0140-6736(02)09411-4","article-title":"Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies","volume":"360","author":"Egger","year":"2002","journal-title":"Lancet"},{"key":"R2-12-20210130","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/S0140-6736(03)14229-8","article-title":"Prognostic importance of initial response in HIV-1 infected patients starting potent antiretroviral therapy: analysis of prospective studies","volume":"362","author":"Chene","year":"2003","journal-title":"Lancet"},{"key":"R3-12-20210130","doi-asserted-by":"crossref","first-page":"946","DOI":"10.7326\/0003-4819-126-12-199706150-00003","article-title":"Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection","volume":"126","author":"Mellors","year":"1997","journal-title":"Ann Intern Med"},{"key":"R4-12-20210130","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1002\/sim.1825","article-title":"Development and validation of a prognostic model for survival time data: application to prognosis of HIV positive patients treated with antiretroviral therapy","volume":"23","author":"May","year":"2003","journal-title":"Stat Med"},{"key":"R5-12-20210130","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.jclinepi.2005.02.015","article-title":"Prognostic model for HIV-1 disease progression in patients starting antiretroviral therapy was validated using independent data","volume":"58","author":"May","year":"2005","journal-title":"J Clin Epidemiol"},{"key":"R6-12-20210130","doi-asserted-by":"crossref","first-page":"401","DOI":"10.7326\/0003-4819-133-6-200009190-00007","article-title":"Clinical outcome of patients with HIV-1 infection according to immunologic and virologic response after 6 months of highly active antiretroviral therapy","volume":"133","author":"Grabar","year":"2000","journal-title":"Ann Intern Med"},{"key":"R7-12-20210130","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1093\/aje\/153.4.386","article-title":"Modeling changes in CD4-positive T-lymphocyte counts after the start of highly active antiretroviral therapy and the relation with risk of opportunistic infections the: Aquitaine Cohort, 1996\u20131997","volume":"153","author":"Binquet","year":"2001","journal-title":"Am J Epidemiol"},{"key":"R8-12-20210130","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1086\/314675","article-title":"Outcome and predictors of failure of highly active antiretroviral therapy: one-year follow-up of a cohort of human immunodeficiency virus type 1-infected persons","volume":"179","author":"Wit","year":"1999","journal-title":"J Infect Dis"},{"key":"R9-12-20210130","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1097\/00002030-200003310-00005","article-title":"Insights into the reasons for discontinuation of the first highly active antiretroviral therapy (HAART) regimen in a cohort of antiretroviral naive patients. I.CO.N.A. Study Group. Italian Cohort of Antiretroviral-Naive Patients","volume":"14","author":"D\u2019Arminio","year":"2000","journal-title":"AIDS"},{"key":"R10-12-20210130","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1136\/bmj.315.7117.1194","article-title":"Impact of new antiretroviral combination therapies in HIV infected patients in Switzerland: prospective multicentre study","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"R11-12-20210130","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1097\/00002030-199714000-00010","article-title":"Changing incidence of AIDS-defining illnesses in the era of antiretroviral combination therapy","volume":"11","author":"Brodt","year":"1997","journal-title":"AIDS"},{"key":"R12-12-20210130","doi-asserted-by":"crossref","first-page":"F113","DOI":"10.1097\/00002030-199714000-00001","article-title":"Virological treatment failure of protease inhibitor therapy in an unselected cohort of HIV-infected patients","volume":"11","author":"Fatkenheuer","year":"1997","journal-title":"AIDS"},{"key":"R13-12-20210130","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/00042560-199711010-00003","article-title":"Regional differences in use of antiretroviral agents and primary prophylaxis in 3122 European HIV-infected patients. EuroSIDA Study Group","volume":"16","author":"Lundgren","year":"1997","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"R14-12-20210130","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1097\/00042560-200101010-00011","article-title":"Zidovudine and stavudine sequencing in HIV treatment planning: findings from the CHORUS HIV cohort","volume":"26","author":"Becker","year":"2001","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R15-12-20210130","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1097\/00002030-199907090-00016","article-title":"The changing pattern of admissions to a London hospital of patients with HIV: 1988\u20131997. Royal Free Centre for HIV Medicine","volume":"13","author":"Mocroft","year":"1999","journal-title":"AIDS"},{"key":"R16-12-20210130","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1097\/00002030-199806000-00011","article-title":"The antiviral effect of ritonavir and saquinavir in combination amongst HIV-infected adults: results from a community-based study","volume":"12","author":"Rhone","year":"1998","journal-title":"AIDS"},{"key":"R17-12-20210130","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1097\/00002030-199816000-00011","article-title":"Predictors of a viral response and subsequent virological treatment failure in patients with HIV starting a protease inhibitor","volume":"12","author":"Mocroft","year":"1998","journal-title":"AIDS"},{"key":"R18-12-20210130","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1097\/00126334-200308010-00010","article-title":"Prevalence of Unsafe Sexual Behavior Among HIV-Infected Individuals: the Swiss HIV Cohort Study","volume":"33","author":"Wolf","year":"2003","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R19-12-20210130","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1093\/ije\/dyh307","article-title":"Causes of death among human immunodeficiency virus (HIV)-infected adults in the era of potent antiretroviral therapy: emerging role of hepatitis and cancers, persistent role of AIDS","volume":"34","author":"Lewden","year":"2005","journal-title":"Int J Epidemiol"},{"key":"R20-12-20210130","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/cncr.20354","article-title":"Malignancy-related causes of death in human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy","volume":"101","author":"Bonnet","year":"2004","journal-title":"Cancer"},{"key":"R21-12-20210130","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.jhep.2005.01.022","article-title":"Liver disease as a major cause of death among HIV infected patients: role of hepatitis C and B viruses and alcohol","volume":"42","author":"Salmon-Ceron","year":"2005","journal-title":"J Hepatol"},{"key":"R22-12-20210130","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1001\/jama.285.13.1736","article-title":"Association of cancer with AIDS-related immunosuppression in adults","volume":"285","author":"Frisch","year":"2001","journal-title":"JAMA"},{"key":"R23-12-20210130","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1093\/jnci\/dji072","article-title":"Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy","volume":"97","author":"Clifford","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"R24-12-20210130","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S0140-6736(06)69152-6","article-title":"HIV treatment response and prognosis in Europe and North America in the first decade of highly active antiretroviral therapy: a collaborative analysis","volume":"368","author":"May","year":"2006","journal-title":"Lancet"},{"key":"R25-12-20210130","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1056\/NEJMsb053133","article-title":"Applying public health principles to the HIV epidemic","volume":"353","author":"Frieden","year":"2005","journal-title":"N Engl J Med"},{"key":"R27-12-20210130","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1136\/bmj.38398.590602.E0","article-title":"Newly diagnosed HIV infections: review in UK and Ireland","volume":"330","author":"Sullivan","year":"2005","journal-title":"BMJ"},{"key":"R28-12-20210130","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1056\/NEJMsa042088","article-title":"Expanded screening for HIV in the United States \u2013 an analysis of cost-effectiveness","volume":"352","author":"Paltiel","year":"2005","journal-title":"N Engl J Med"}],"container-title":["AIDS"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/QAD.0b013e328133f285","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T16:42:42Z","timestamp":1786034562000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00002030-200705310-00012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5,31]]},"references-count":27,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1097\/qad.0b013e328133f285","relation":{},"ISSN":["0269-9370"],"issn-type":[{"value":"0269-9370","type":"print"}],"subject":[],"published":{"date-parts":[[2007,5,31]]}}}